As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

The U.S. Food and Drug Administration (FDA) on Tuesday approved a new, simplified monthly dosing schedule for Johnson & ...

Eli Lilly and Co. LLY on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for Retevmo ...

Dr. Douglas Wood, Henry N. Harkins Endowed Professor, chair of the UW Medicine department of surgery, and recipient of the UW ...

Patients with stage 4 lung cancer and EGFR mutations may benefit from combination therapies that improve disease control. The American Society of Clinical Oncology (ASCO) released updated treatment ...

About a decade later, the U.S. Preventive Services Taskforce (USPSTF) issued updated guidelines recommending annual screening for lung cancer with low-dose CT for adults ages 50 to 80 years with a 20 ...

“Long travel times and costs associated with travel can be a significant burden for many cancer patients living in rural ...

Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...

KRAS is the most frequently mutated oncogene across all human cancers. Although different KRAS mutations have long been thought to exert the same cancer-driving effects, a new study led by UT ...

The American Lung Association is working to highlight the importance of lung cancer screening.

When Beverley Moir, a lifelong non-smoker, developed a second lingering cold within six months, she was coughing so severely she thought she had strep throat. She booked an appointment with her family ...